journal article·2025-08Open access

Molten‐Salt‐Mediated Synthesis of Atomic Manganese/Cobalt Catalysts on Bioceramic Microparticles for Catalytic Anti‐Osteoarthritis Treatments

Ronghui Deng, Zining Zhang, Aijun Wu, Chaoqin Shu, Shitang Song, Fuzhen Yuan, Zijie Xu, Meng Yang, Jing Ye, Yifan Song, Yufang Zhu, Jia‐Kuo Yu

Advanced Science· Volume 12· Issue 31

Abstract

Abstract Osteoarthritis (OA) is a chronic progressive joint disease characterized by cartilage degeneration and local inflammation, and its progression is closely related to the excessive production of reactive oxygen species (ROS). Despite progress made with small molecule antioxidants and nanozymes, effective antioxidant therapy for the long‐term elimination of these ROS remains challenging, largely due to the rapid clearance of antioxidants from the joints via synovial vessels and lymphatics. Herein, a molten‐salt method is developed to facilitate the atomic dispersion of Mn or Co ions homogeneously on the surface of akermanite microparticles (AKT‐MPs). The micrometer‐scale Mn‐ or Co‐AKT‐MPs with multi‐mimetic enzyme effects are demonstrated to obliterate multiple ROS, thereby protecting the inherent homeostasis between chondrocyte anabolism and catabolism, while suppressing the conversion of macrophages to a pro‐inflammatory phenotype. In addition, the microparticles exhibited chondroprotection of ROS‐challenged cartilage explants in vitro by limiting the loss of cartilage extracellular matrix (ECM) and the release of degradative enzymes. Furthermore, Mn‐ or Co‐AKT‐MPs are injected intra‐articularly into monosodium iodoacetate (MIA)‐induced OA mice and effectively suppress synovial inflammation, painful symptoms, and progression of early cartilage destruction. Therefore, this microparticle‐based antioxidant therapy provides an insight and paradigm to control atomic catalysts integrated with microparticles for efficient catalytic anti‐OA treatments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Extracellular vesicles in disease · Osteoarthritis Treatment and Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Sports Medicine Department Beijing Key Laboratory of Sports Injuries Peking University Third Hospital Beijing 100191 P. R. China

Peking University Institute of Sports Medicine Beijing 100191 P. R. China

Orthopaedic and Sports Medicine Center Beijing Tsinghua Changgung Hospital Tsinghua University Beijing 102218 P. R. China

State Key Laboratory of High Performance Ceramics and Superfine Microstructure Shanghai Institute of Ceramics Chinese Academy of Sciences Shanghai 200050 P. R. China

Center of Materials Science and Optoelectronics Engineering University of Chinese Academy of Sciences Beijing 100049 P. R. China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (55)

Show source-provided references
1. 10.1056/NEJMcp190376810.1056/NEJMcp1903768 ↗
2. 10.1038/s41584-021-00673-410.1038/s41584-021-00673-4 ↗
3. 10.1038/s41584-020-00523-910.1038/s41584-020-00523-9 ↗
4. 10.1038/s41584-023-00979-510.1038/s41584-023-00979-5 ↗
5. 10.1038/s41584-020-00518-610.1038/s41584-020-00518-6 ↗
6. 10.1001/jama.2020.2217110.1001/jama.2020.22171 ↗
7. 10.1016/S0140-6736(19)30417-910.1016/S0140-6736(19)30417-9 ↗
8. 10.1038/s41392-023-01330-w10.1038/s41392-023-01330-w ↗
9. 10.1038/nrrheum.2016.13610.1038/nrrheum.2016.136 ↗
10. 10.1038/s41584-022-00749-910.1038/s41584-022-00749-9 ↗
11. 10.1038/nrrheum.2016.6510.1038/nrrheum.2016.65 ↗
12. 10.1016/j.biomaterials.2022.12143710.1016/j.biomaterials.2022.121437 ↗
13. 10.1021/acsnano.3c0178910.1021/acsnano.3c01789 ↗
14. 10.1002/advs.20220687510.1002/advs.202206875 ↗
15. 10.1126/scitranslmed.aan537210.1126/scitranslmed.aan5372 ↗
16. 10.1038/s41467-022-28385-710.1038/s41467-022-28385-7 ↗
17. 10.1038/s41467-020-17242-010.1038/s41467-020-17242-0 ↗
18. 10.1021/acsnano.9b0299310.1021/acsnano.9b02993 ↗
19. 10.1002/adma.20220271510.1002/adma.202202715 ↗
20. 10.1016/j.actbio.2023.03.03010.1016/j.actbio.2023.03.030 ↗
21. 10.1016/j.ijpharm.2020.11994710.1016/j.ijpharm.2020.119947 ↗
22. 10.1093/rheumatology/kem11610.1093/rheumatology/kem116 ↗
23. 10.1016/j.biomaterials.2019.11946710.1016/j.biomaterials.2019.119467 ↗
24. 10.1002/adma.20230329910.1002/adma.202303299 ↗
25. 10.1002/adma.20230412310.1002/adma.202304123 ↗
26. 10.1038/nrrheum.2016.21010.1038/nrrheum.2016.210 ↗
27. 10.1021/acsnano.1c0400510.1021/acsnano.1c04005 ↗
28. 10.1038/s41551-021-00780-310.1038/s41551-021-00780-3 ↗
29. 10.1038/s41551-023-01025-110.1038/s41551-023-01025-1 ↗
30. 10.1021/acsnano.2c0639310.1021/acsnano.2c06393 ↗
31. 10.1007/s40265-019-01083-310.1007/s40265-019-01083-3 ↗
32. 10.1021/acs.chemrev.8b0067210.1021/acs.chemrev.8b00672 ↗
33. 10.1002/adma.20221121010.1002/adma.202211210 ↗
34. 10.1002/adma.20221172410.1002/adma.202211724 ↗
35. 10.1021/acscentsci.0c0051210.1021/acscentsci.0c00512 ↗
36. 10.1002/anie.20191218210.1002/anie.201912182 ↗
37. 10.1002/adma.20210377010.1002/adma.202103770 ↗
38. 10.1038/s41563-019-0328-110.1038/s41563-019-0328-1 ↗
39. 10.1038/s41586-022-04983-910.1038/s41586-022-04983-9 ↗
40. 10.1002/adma.20240116310.1002/adma.202401163 ↗
41. 10.1002/adma.20210377010.1002/adma.202103770 ↗
42. 10.1021/acs.accounts.2c0085510.1021/acs.accounts.2c00855 ↗
43. 10.1002/advs.20210572710.1002/advs.202105727 ↗
44. 10.1002/anie.20200114810.1002/anie.202001148 ↗
45. 10.1038/s41563-020-0657-010.1038/s41563-020-0657-0 ↗
46. 10.1002/art.4250510.1002/art.42505 ↗
47. 10.1016/j.redox.2016.12.03510.1016/j.redox.2016.12.035 ↗
48. 10.1038/s41565-022-01261-710.1038/s41565-022-01261-7 ↗
49. 10.1002/anie.20180615910.1002/anie.201806159 ↗
50. 10.1038/nrdp.2016.7210.1038/nrdp.2016.72 ↗
51. 10.1136/annrheumdis-2018-21345010.1136/annrheumdis-2018-213450 ↗
52. 10.1016/j.tox.2017.05.01510.1016/j.tox.2017.05.015 ↗
53. 10.1016/j.biomaterials.2021.12112710.1016/j.biomaterials.2021.121127 ↗
54. 10.1016/j.jpain.2008.05.01210.1016/j.jpain.2008.05.012 ↗
55. 10.1016/j.joca.2010.07.01310.1016/j.joca.2010.07.013 ↗